Handa Pharmaceuticals, Inc. (TPEX:6620)
Taiwan · Delayed Price · Currency is TWD 78.60
-2.10 (-2.60%)
Apr 20, 2026, 1:20 PM CST
Handa Pharmaceuticals Revenue
In the year 2025, Handa Pharmaceuticals had annual revenue of 1.73B TWD with 108.17% growth. Handa Pharmaceuticals had revenue of 299.92M in the quarter ending December 31, 2025, with 59.45% growth.
Revenue
1.73B
Revenue Growth
+108.17%
P/S Ratio
7.72
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.73B | 898.58M | 108.17% |
| Dec 31, 2024 | 830.67M | -275.65M | -24.92% |
| Dec 31, 2023 | 1.11B | 908.64M | 459.66% |
| Dec 31, 2022 | 197.68M | 168.44M | 576.16% |
| Dec 31, 2021 | 29.24M | 376.00K | 1.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grape King Bio | 10.25B |
| YungShin Global Holding | 8.38B |
| Standard Chemical & Pharmaceutical | 7.02B |
| TTY Biopharm Company | 6.45B |
| Synmosa Biopharma | 6.19B |
| Formosa Laboratories | 4.85B |
| ScinoPharm Taiwan | 3.16B |
| Center Laboratories | 1.52B |